Analysis & Opinions - The Atlantic
Don't Wait for Herd Immunity
We may never reach the point when viral spread stops, but a strategy of minimizing risk—not eliminating it—can help Americans reclaim normalcy.
Featured in the Belfer Center Spring 2021 Newsletter »
With 200 million doses administered, America's vaccine-distribution program has been remarkably successful, but now it is hitting a wall. The rate of COVID-19 vaccinations is dropping; the percentage of people not returning for their second shot has risen. Fortunately, the number of Americans who are resolutely anti-vaccine remains small, a stubborn 13 percent, so finding ways to win over the rest remains an urgent task.
The underlying reality ought to be discussed more forthrightly. The United States may not reach the point at which enough people have become immune—by either getting vaccinated or having overcome a previous infection—and the coronavirus cannot spread in the population. This has been evident for some time. "We likely won't cross the threshold of herd immunity," Sarah Zhang wrote in The Atlantic in February. Yet the elusive possibility of herd immunity continues to shape Americans' expectations. Getting there would simplify many questions about lifting mask orders and business restrictions, but mayors and governors who are reluctant to take such steps without a green light from scientists could be waiting for a long time.
The idea that a pandemic ends once the population reaches herd immunity has historical precedent. Last year, that notion took a macabre turn, as some within the Trump administration proposed letting natural infections rip through the population. The more humane route to herd immunity, embraced by the nation's most prominent infectious-disease experts, was for Americans to listen to scientists and get a couple of shots....
Want to Read More?
The full text of this publication is available via The Atlantic.
For more information on this publication:
Belfer Communications Office
For Academic Citation:
Kayyem, Juliette.“Don't Wait for Herd Immunity.” The Atlantic, April 29, 2021.
- Recommended
- In the Spotlight
- Most Viewed
Recommended
Analysis & Opinions
- Science
Scientists' Lanes and Headwinds
Journal Article
- Journal of Applied History
To Boldly Remember Where We Have Already Been
Analysis & Opinions
- CNN
The Unrelenting Horizonlessness of the Covid World
In the Spotlight
Most Viewed
Audio
- Harvard Environmental Economics Program
Previewing COP 28: A Conversation with Nat Keohane
Policy Brief
- Quarterly Journal: International Security
Oil, Conflict, and U.S. National Interests
News
- Harvard Project on Climate Agreements
Harvard Project to Conduct Panel on Methane Emissions Abatement at COP-28
Featured in the Belfer Center Spring 2021 Newsletter »
With 200 million doses administered, America's vaccine-distribution program has been remarkably successful, but now it is hitting a wall. The rate of COVID-19 vaccinations is dropping; the percentage of people not returning for their second shot has risen. Fortunately, the number of Americans who are resolutely anti-vaccine remains small, a stubborn 13 percent, so finding ways to win over the rest remains an urgent task.
The underlying reality ought to be discussed more forthrightly. The United States may not reach the point at which enough people have become immune—by either getting vaccinated or having overcome a previous infection—and the coronavirus cannot spread in the population. This has been evident for some time. "We likely won't cross the threshold of herd immunity," Sarah Zhang wrote in The Atlantic in February. Yet the elusive possibility of herd immunity continues to shape Americans' expectations. Getting there would simplify many questions about lifting mask orders and business restrictions, but mayors and governors who are reluctant to take such steps without a green light from scientists could be waiting for a long time.
The idea that a pandemic ends once the population reaches herd immunity has historical precedent. Last year, that notion took a macabre turn, as some within the Trump administration proposed letting natural infections rip through the population. The more humane route to herd immunity, embraced by the nation's most prominent infectious-disease experts, was for Americans to listen to scientists and get a couple of shots....
Want to Read More?
The full text of this publication is available via The Atlantic.- Recommended
- In the Spotlight
- Most Viewed
Recommended
Analysis & Opinions - Science
Scientists' Lanes and Headwinds
Journal Article - Journal of Applied History
To Boldly Remember Where We Have Already Been
Analysis & Opinions - CNN
The Unrelenting Horizonlessness of the Covid World
In the Spotlight
Most Viewed
Audio - Harvard Environmental Economics Program
Previewing COP 28: A Conversation with Nat Keohane
Policy Brief - Quarterly Journal: International Security
Oil, Conflict, and U.S. National Interests
News - Harvard Project on Climate Agreements
Harvard Project to Conduct Panel on Methane Emissions Abatement at COP-28